Product Information
PERPHENAZINE 4 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1413 per EA under NDC 68382059201. Its NADAC has been published 279 times since Feb 24, 2021.
Strength
4 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382059201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PERPHENAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA205232On Market Since
7/16/2020
Pharmacological Classes
Price Statistics
The NADAC for PERPHENAZINE 4 MG TABLET has been published 279 times since Feb 24, 2021, and over the history we have for it it has declined 66.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1413 per EA |
|---|---|
| All-time high | $0.4823 (May 12, 2021) |
| All-time low | $0.1413 (Jun 17, 2026) |
| 52-week high | $0.2228 |
| 52-week low | $0.1413 |
| Median price | $0.2478 |
| Average price | $0.2674 |
| Largest weekly change | +63.8% (Dec 21, 2022) |
| Weeks tracked | 279 |
| Tracking since | Feb 24, 2021 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PERPHENAZINE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PERPHENAZINE 4 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1413 per EA (NDC 68382059201), effective Jun 24, 2026.
How has the price of PERPHENAZINE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for PERPHENAZINE 4 MG TABLET has declined 66.6%. It has been tracked across 279 weekly CMS publications since Feb 24, 2021.
What are the highest and lowest recorded NADAC prices for PERPHENAZINE 4 MG TABLET?
Since Feb 24, 2021, the NADAC for PERPHENAZINE 4 MG TABLET has ranged from a low of $0.1413 (Jun 17, 2026) to a high of $0.4823 (May 12, 2021), with a median of $0.2478 per EA.
Are there cheaper alternatives to PERPHENAZINE 4 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as PERPHENAZINE 4 MG TABLET, but none are currently priced below it.
Who manufactures PERPHENAZINE 4 MG TABLET?
PERPHENAZINE 4 MG TABLET (NDC 68382059201) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification